FDA Approves Pfizer, Moderna Covid Booster Shots

The video discusses the impact of COVID-19 booster shots on the stocks of Moderna and Pfizer. It highlights how state regulations have influenced market reactions, with Moderna being more affected due to its reliance on COVID-19 sales. The video also examines Pfizer's revenue dependency on the COVID-19 vaccine, despite its diverse business portfolio.

In what way are Moderna and Pfizer's business models different regarding COVID-19 sales?

What impact does the approval of additional COVID-19 doses have on the companies involved?